ALT
Price
$7.66
Change
-$0.22 (-2.79%)
Updated
Sep 16, 02:58 PM (EDT)
50 days until earnings call
INZY
Price
$6.00
Change
+$0.38 (+6.76%)
Updated
Sep 13 closing price
50 days until earnings call
Ad is loading...

ALT vs INZY

Header iconALT vs INZY Comparison
Open Charts ALT vs INZYBanner chart's image
Altimmune
Price$7.66
Change-$0.22 (-2.79%)
Volume$2.61K
CapitalizationN/A
Inozyme Pharma
Price$6.00
Change+$0.38 (+6.76%)
Volume$399.19K
CapitalizationN/A
View a ticker or compare two or three
ALT vs INZY Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALT vs. INZY commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and INZY is a Buy.

COMPARISON
Comparison
Sep 16, 2024
Stock price -- (ALT: $7.88 vs. INZY: $6.00)
Brand notoriety: ALT and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 203% vs. INZY: 143%
Market capitalization -- ALT: $560.04M vs. INZY: $402.59M
ALT [@Biotechnology] is valued at $560.04M. INZY’s [@Biotechnology] market capitalization is $402.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $606.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while INZY’s TA Score has 5 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 5 bearish.
  • INZY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than ALT.

Price Growth

ALT (@Biotechnology) experienced а +27.10% price change this week, while INZY (@Biotechnology) price change was +20.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.24%. For the same industry, the average monthly price growth was +4.38%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

ALT is expected to report earnings on Nov 05, 2024.

INZY is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (+2.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($560M) has a higher market cap than INZY($403M). INZY YTD gains are higher at: 40.845 vs. ALT (-29.956). INZY has higher annual earnings (EBITDA): -82.82M vs. ALT (-100.91M). ALT has more cash in the bank: 165M vs. INZY (145M). ALT has less debt than INZY: ALT (1.86M) vs INZY (46.7M). ALT has higher revenues than INZY: ALT (409K) vs INZY (0).
ALTINZYALT / INZY
Capitalization560M403M139%
EBITDA-100.91M-82.82M122%
Gain YTD-29.95640.845-73%
P/E RatioN/AN/A-
Revenue409K0-
Total Cash165M145M114%
Total Debt1.86M46.7M4%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTINZY
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BASAX22.080.36
+1.66%
Brown Advisory Small-Cap Growth Adv
KGIIX14.100.18
+1.29%
Kopernik International I
MECEX14.350.08
+0.56%
NYLI Epoch Capital Growth Class C
URNQX49.020.24
+0.49%
Victory Nasdaq 100 Index R6
NUGIX37.210.10
+0.27%
Nuveen Global Dividend Growth I

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with EDIT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
+10.99%
EDIT - ALT
43%
Loosely correlated
+5.33%
VKTX - ALT
42%
Loosely correlated
+6.24%
INZY - ALT
42%
Loosely correlated
+6.76%
PLRX - ALT
42%
Loosely correlated
+1.35%
KRYS - ALT
41%
Loosely correlated
+3.04%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+6.76%
BEAM - INZY
58%
Loosely correlated
+7.79%
NTLA - INZY
54%
Loosely correlated
+6.77%
FULC - INZY
51%
Loosely correlated
-7.56%
DNLI - INZY
50%
Loosely correlated
+10.05%
PLRX - INZY
49%
Loosely correlated
+1.35%
More